Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210.

Article  CAS  PubMed  Google Scholar 

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. (https://gcoiarc.fr/today). Accesed 20 Sept 2022. 2020.

McGranahan N, Swanton C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell. 2017;168(4):613–28. https://doi.org/10.1016/j.cell.2017.01.018.

Article  CAS  PubMed  Google Scholar 

Dhyani P, Quispe C, Sharma E, Bahukhandi A, Sati P, Attri DC, et al. Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell Int. 2022;22(1):206. https://doi.org/10.1186/s12935-022-02624-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ozkan G, Günal-Köroğlu D, Karadag A, Capanoglu E, Cardoso SM, Al-Omari B, et al. A mechanistic updated overview on lycopene as potential anticancer agent. Biomed Pharmacother. 2023;161:114428. https://doi.org/10.1016/j.biopha.2023.114428.

Article  CAS  PubMed  Google Scholar 

Sova M, Saso L. Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review. Drug Des Devel Ther. 2018;12:3181–97. https://doi.org/10.2147/DDDT.S172612.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anantharaju PG, Gowda PC, Vimalambike MG, Madhunapantula SV. An overview on the role of dietary phenolics for the treatment of cancers. Nutr J. 2016;15(1):99. https://doi.org/10.1186/s12937-016-0217-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasher P, Sharma M, Sharma AK, Sharifi-Rad J, Calina D, Hano C, et al. Key oncologic pathways inhibited by Erinacine A: A perspective for its development as an anticancer molecule. Biomedicine & Pharmacotherapy. 2023;160:114332. https://doi.org/10.1016/j.biopha.2023.114332.

Article  CAS  Google Scholar 

Mititelu RR, Padureanu R, Bacanoiu M, Padureanu V, Docea AO, Calina D, et al. Inflammatory and Oxidative Stress Markers-Mirror Tools in Rheumatoid Arthritis. Biomedicines. 2020;8(5). https://doi.org/10.3390/biomedicines8050125.

Kostoff RN, Kanduc D, Porter AL, Shoenfeld Y, Calina D, Briggs MB, et al. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol Rep. 2020;7:1448–58. https://doi.org/10.1016/j.toxrep.2020.10.016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang K, Jiang J, Lei Y, Zhou S, Wei Y, Huang C. Targeting Metabolic-Redox Circuits for Cancer Therapy. Trends Biochem Sci. 2019;44(5):401–14. https://doi.org/10.1016/j.tibs.2019.01.001.

Article  CAS  PubMed  Google Scholar 

Pezzani R, Jiménez-Garcia M, Capó X, Sönmez Gürer E, Sharopov F, Rachel TYL, et al. Anticancer properties of bromelain: State-of-the-art and recent trends. Front Oncol. 2023;12. https://doi.org/10.3389/fonc.2022.1068778.

Garzoli S, Alarcón-Zapata P, Seitimova G, Alarcón-Zapata B, Martorell M, Sharopov F, et al. Natural essential oils as a new therapeutic tool in colorectal cancer. Cancer Cell Int. 2022;22(1):407. https://doi.org/10.1186/s12935-022-02806-5.

Article  PubMed  PubMed Central  Google Scholar 

Ju HQ, Gocho T, Aguilar M, Wu M, Zhuang ZN, Fu J, et al. Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation. Mol Cancer Ther. 2015;14(3):788–98. https://doi.org/10.1158/1535-7163.MCT-14-0420.

Article  CAS  PubMed  Google Scholar 

Sharifi-Rad J, Bahukhandi A, Dhyani P, Sati P, Capanoglu E, Docea AO, et al. Therapeutic Potential of Neoechinulins and Their Derivatives: An Overview of the Molecular Mechanisms Behind Pharmacological Activities. Front Nutr. 2021;8:664197. https://doi.org/10.3389/fnut.2021.664197.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Tian Z, Guo R, Ren F. Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways. Oxid Med Cell Longev. 2020;2020:9867595. https://doi.org/10.1155/2020/9867595.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robledinos-Anton N, Fernandez-Gines R, Manda G, Cuadrado A. Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development. Oxid Med Cell Longev. 2019;2019:9372182. https://doi.org/10.1155/2019/9372182.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, et al. Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer. J Clin Oncol. 2018;36(1):7–13. https://doi.org/10.1200/jco.2017.73.6785.

Article  CAS  PubMed  Google Scholar 

Milkovic L, Zarkovic N, Saso L. Controversy about pharmacological modulation of Nrf2 for cancer therapy. Redox Biol. 2017;12:727–32. https://doi.org/10.1016/j.redox.2017.04.013.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lisek K, Campaner E, Ciani Y, Walerych D, Del Sal G. Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells. Oncotarget. 2018;9(29):20508–23. https://doi.org/10.18632/oncotarget.24974.

Article  PubMed  PubMed Central  Google Scholar 

Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236(2):313–22. https://doi.org/10.1006/bbrc.1997.6943.

Article  CAS  PubMed  Google Scholar 

Telkoparan-Akillilar P, Suzen S, Saso L. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs. Int J Mol Sci. 2019;20(8):2025. https://doi.org/10.3390/ijms20082025.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okawa H, Motohashi H, Kobayashi A, Aburatani H, Kensler TW, Yamamoto M. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun. 2006;339(1):79–88. https://doi.org/10.1016/j.bbrc.2005.10.185.

Article  CAS  PubMed  Google Scholar 

Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer. 2012;12(8):564–71. https://doi.org/10.1038/nrc3278.

Article  CAS  PubMed  Google Scholar 

Cescon DW, She D, Sakashita S, Zhu CQ, Pintilie M, Shepherd FA, et al. NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma. Clin Cancer Res. 2015;21(11):2499–505. https://doi.org/10.1158/1078-0432.CCR-14-2206.

Article  CAS  PubMed  Google Scholar 

Cho HY, Kwak MK, Pi J. Nrf2 in host defense: over the rainbow. Oxid Med Cell Longev. 2013;2013:975839. https://doi.org/10.1155/2013/975839.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sajadimajd S, Khazaei M. Oxidative Stress and Cancer: The Role of Nrf2. Curr Cancer Drug Targets. 2018;18(6):538–57. https://doi.org/10.2174/1568009617666171002144228.

Article  CAS  PubMed  Google Scholar 

Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the Hallmarks of Cancer. Cancer Cell. 2018;34(1):21–43. https://doi.org/10.1016/j.ccell.2018.03.022.

Article  CAS  PubMed  Google Scholar 

Coêlho ML, Islam MT, Laylson da Silva Oliveira G, Oliveira Barros de Alencar MV, Victor de Oliveira Santos J, Campinho dos Reis A, et al. Cytotoxic and Antioxidant Properties of Natural Bioactive Monoterpenes Nerol, Estragole, and 3,7-Dimethyl-1-Octanol. Adv Pharmacol Pharm Sci. 2022;2022:8002766. https://doi.org/10.1155/2022/8002766.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, Jiang Z, Lu H, Xu Z, Tong R, Shi J, et al. Recent Advances of Natural Polyphenols Activators for Keap1-Nrf2 Signaling Pathway. Chem Biodivers. 2019;16(11):e1900400. https://doi.org/10.1002/cbdv.201900400.

Article  CAS  PubMed  Google Scholar 

Huang WY, Cai YZ, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer. 2010;62(1):1–20. https://doi.org/10.1080/01635580903191585.

Article  CAS  PubMed  Google Scholar 

Subramaniam S, Selvaduray KR, Radhakrishnan AK. Bioactive Compounds: Natural Defense Against Cancer? Biomolecules. 2019;9(12):758. https://doi.org/10.3390/biom9120758.

Article  CAS  PubMed  PubMed Central  Google Scholar 

WFO: WFO The World Flora Online. http://www.worldfloraonline.org/. (2021). Accessed.

PubChem: Explore Chemistry. https://pubchem.ncbi.nlm.nih.gov/. Accessed.

Sharifi-Rad J, Quispe C, Herrera-Bravo J, Martorell M, Sharopov F, Tumer TB, et al. A Pharmacological Perspective on Plant-derived Bioactive Molecules for Epilepsy. Neurochem Res. 2021;46(9):2205–25. https://doi.org/10.1007/s11064-021-03376-0.

Article  CAS  PubMed  Google Scholar 

Sharifi-Rad J, Kamiloglu S, Yeskaliyeva B, Beyatli A, Alfred MA, Salehi B, et al. Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action. Front Pharmacol. 2020;11:11. https://doi.org/10.3389/fphar.2020.571459.

Article  CAS  Google Scholar 

Sharifi-Rad J, Cruz-Martins N, López-Jornet P, Lopez EP-F, Harun N, Yeskaliyeva B, et al. Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms. Oxidative Med Cell Longevity. 2021;2021:6492346. https://doi.org/10.1155/2021/6492346.

Article  CAS